Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.

Cell communication and signaling : CCS - 19 Dec 2017

Jiang Yang, Han Sheng, Cheng Wen, Wang Zixun, Wu Anhua

Abstract excerpt

BACKGROUND: We previously demonstrated that the local immune status correlated with the glioma prognosis. Interleukin-6 (IL6) was identified as an important local immune-related risk marker related to unfavourable prognosis. In this study, we further investigated the role and regulation of IL6 signalling in glioma. METHODS: The expression and prognostic value of IL6 and the IL6 receptor (IL6R) were explored in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Proliferation
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Knockdown Techniques

Share to Glioma

Share to Interleukin-6

Share to Neoplasm Invasiveness

Share to NFATC Transcription Factors

Share to Receptors, Interleukin-6

Source

Open in PubMed Open full text

Identifiers

PMID: 29258522
DOI: 10.1186/s12964-017-0210-1
PMCID: PMC5735798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.PMID 29258522Read ↗

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in GliomasSemantic proximity Read ↗

Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical ValidationSemantic proximity Read ↗

Bioinformatic profiling identifies an immune-related risk signature for glioblastomaSemantic proximity Read ↗

Molecular subtypes and prognostic analysis of cytokine-related genes in gliomasSemantic proximity Read ↗

Integrin Alpha L as an Immune-Related Biomarker Correlated with the Prognosis and Effect of Immunotherapy in GliomasSemantic proximity Read ↗

SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insightsSemantic proximity Read ↗

CDC6 is a prognostic biomarker and correlated with immune infiltrates in gliomaSemantic proximity Read ↗

High PRMT6 expression Associated With Prognosis and Immune Infiltration in GliomaSemantic proximity Read ↗

High Expression of PRMT6 Associated With Prognosis and Immune Infiltration in GliomaSemantic proximity Read ↗

Elevated expression of IL-10RB acts as an independent unfavorable prognostic marker and predicts the polarization of tumor-associated macrophages in gliomaSemantic proximity Read ↗

Correlations of IL-18 and IL-6 gene polymorphisms and expression levels with onset of glioma.Semantic proximity Read ↗

MUL1, an Immune Chemokine-Related Gene, Regulates Glioma Cell Proliferation and Migration: Insights from Functional and Mechanistic StudiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.